Cargando…
Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study
PURPOSE: The Oxathiazinane substance class is characterized by a high diversity of chemical structures yet to be fully investigated. Our research group recently proved that the 1.4.5-oxathiazine-4.4-dioxide, known as substance GP-2250, possesses antineoplastic properties as shown on pancreatic carci...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374762/ https://www.ncbi.nlm.nih.gov/pubmed/37171614 http://dx.doi.org/10.1007/s00432-023-04799-8 |
_version_ | 1785078846634065920 |
---|---|
author | Majchrzak-Stiller, B. Buchholz, M. Peters, I. Strotmann, J. Möhrke, J. Zelichowski, L. Oehlke, L. Quensel, C. Fein, D. Höhn, P. Müller, T. Uhl, W. Braumann, C. |
author_facet | Majchrzak-Stiller, B. Buchholz, M. Peters, I. Strotmann, J. Möhrke, J. Zelichowski, L. Oehlke, L. Quensel, C. Fein, D. Höhn, P. Müller, T. Uhl, W. Braumann, C. |
author_sort | Majchrzak-Stiller, B. |
collection | PubMed |
description | PURPOSE: The Oxathiazinane substance class is characterized by a high diversity of chemical structures yet to be fully investigated. Our research group recently proved that the 1.4.5-oxathiazine-4.4-dioxide, known as substance GP-2250, possesses antineoplastic properties as shown on pancreatic carcinoma. This current study aims to gain insights into the structure and activity relationship of a series of different Oxathiazinanes regarding their antineoplastic activity and the potential correlation with antibacterial activity. We investigated the newly synthesized Oxathiazinane derivatives: 2255, 2256, 2287, 2289, 2293 and 2296 in comparison to GP-2250. METHODS: The antineoplastic effect was evaluated in different cancer entities (breast, skin, pancreas and colon cancer cell lines) by viability, proliferation, and cell migration assays in vitro. Disc diffusion tests were performed on various bacteria strains to examine the antibacterial potential. Additionally, reactive oxygen species (ROS) assays were conducted to investigate mechanistic aspects. RESULTS: The substances GP-2250, 2293, 2289 and 2296 not only showed antineoplastic activity in four different cancer entities but also antibacterial effects, as tested on multiple bacteria strains including MRSA (Methicillin-resistant Staphylococcus aureus). Furthermore, these substances also induced high ROS levels up to 110% in the treated cancer cell lines compared to untreated control cells. These results indicate a correlation between an antineoplastic capacity and antibacterial properties of these derivatives. Both activities appear to be ROS driven. The Oxathiazinane derivatives 2255, 2256 and 2287 lacked both, antineoplastic and antibacterial activity. CONCLUSION: Thus, a comparable structure activity relationship became apparent for both the antineoplastic and antibacterial activity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04799-8. |
format | Online Article Text |
id | pubmed-10374762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-103747622023-07-29 Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study Majchrzak-Stiller, B. Buchholz, M. Peters, I. Strotmann, J. Möhrke, J. Zelichowski, L. Oehlke, L. Quensel, C. Fein, D. Höhn, P. Müller, T. Uhl, W. Braumann, C. J Cancer Res Clin Oncol Research PURPOSE: The Oxathiazinane substance class is characterized by a high diversity of chemical structures yet to be fully investigated. Our research group recently proved that the 1.4.5-oxathiazine-4.4-dioxide, known as substance GP-2250, possesses antineoplastic properties as shown on pancreatic carcinoma. This current study aims to gain insights into the structure and activity relationship of a series of different Oxathiazinanes regarding their antineoplastic activity and the potential correlation with antibacterial activity. We investigated the newly synthesized Oxathiazinane derivatives: 2255, 2256, 2287, 2289, 2293 and 2296 in comparison to GP-2250. METHODS: The antineoplastic effect was evaluated in different cancer entities (breast, skin, pancreas and colon cancer cell lines) by viability, proliferation, and cell migration assays in vitro. Disc diffusion tests were performed on various bacteria strains to examine the antibacterial potential. Additionally, reactive oxygen species (ROS) assays were conducted to investigate mechanistic aspects. RESULTS: The substances GP-2250, 2293, 2289 and 2296 not only showed antineoplastic activity in four different cancer entities but also antibacterial effects, as tested on multiple bacteria strains including MRSA (Methicillin-resistant Staphylococcus aureus). Furthermore, these substances also induced high ROS levels up to 110% in the treated cancer cell lines compared to untreated control cells. These results indicate a correlation between an antineoplastic capacity and antibacterial properties of these derivatives. Both activities appear to be ROS driven. The Oxathiazinane derivatives 2255, 2256 and 2287 lacked both, antineoplastic and antibacterial activity. CONCLUSION: Thus, a comparable structure activity relationship became apparent for both the antineoplastic and antibacterial activity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04799-8. Springer Berlin Heidelberg 2023-05-12 2023 /pmc/articles/PMC10374762/ /pubmed/37171614 http://dx.doi.org/10.1007/s00432-023-04799-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Majchrzak-Stiller, B. Buchholz, M. Peters, I. Strotmann, J. Möhrke, J. Zelichowski, L. Oehlke, L. Quensel, C. Fein, D. Höhn, P. Müller, T. Uhl, W. Braumann, C. Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study |
title | Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study |
title_full | Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study |
title_fullStr | Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study |
title_full_unstemmed | Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study |
title_short | Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study |
title_sort | oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374762/ https://www.ncbi.nlm.nih.gov/pubmed/37171614 http://dx.doi.org/10.1007/s00432-023-04799-8 |
work_keys_str_mv | AT majchrzakstillerb oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT buchholzm oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT petersi oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT strotmannj oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT mohrkej oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT zelichowskil oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT oehlkel oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT quenselc oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT feind oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT hohnp oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT mullert oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT uhlw oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy AT braumannc oxathiazinanederivativesdisplaybothantineoplasticandantibacterialactivityastructureactivitystudy |